Literature DB >> 26401634

Hybrid minimally invasive esophagectomy for cancer: impact on postoperative inflammatory and nutritional status.

M Scarpa1, F Cavallin1, L M Saadeh1, E Pinto1, R Alfieri1, M Cagol1, A Da Roit1, E Pizzolato1, G Noaro1, G Pozza1, C Castoro1.   

Abstract

The purpose of this case-control study was to evaluate the impact of hybrid minimally invasive esophagectomy for cancer on surgical stress response and nutritional status. All 34 consecutive patients undergoing hybrid minimally invasive esophagectomy for cancer at our surgical unit between 2008 and 2013 were retrospectively compared with 34 patients undergoing esophagectomy with open gastric tubulization (open), matched for neoadjuvant therapy, pathological stage, gender and age. Demographic data, tumor features and postoperative course (including quality of life and systemic inflammatory and nutritional status) were compared. Postoperative course was similar in terms of complication rate. Length of stay in intensive care unit was shorter in patients undergoing hybrid minimally invasive esophagectomy (P = 0.002). In the first postoperative day, patients undergoing hybrid minimally invasive esophagectomy had lower C-reactive protein levels (P = 0.001) and white cell blood count (P = 0.05), and higher albumin serum level (P = 0.001). In this group, albumin remained higher also at third (P = 0.06) and seventh (P = 0.008) postoperative day, and C-reactive protein resulted lower at third post day (P = 0.04). Hybrid minimally invasive esophagectomy significantly improved the systemic inflammatory and catabolic response to surgical trauma, contributing to a shorter length of stay in intensive care unit.
© 2015 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  esophageal cancer; esophagectomy; inflammation response; minimally invasive

Mesh:

Substances:

Year:  2015        PMID: 26401634     DOI: 10.1111/dote.12418

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  17 in total

1.  The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer.

Authors:  Kun-Kun Li; Yin-Jian Wang; Xue-Hai Liu; Qun-You Tan; Yao-Guang Jiang; Wei Guo
Journal:  Surg Endosc       Date:  2016-12-06       Impact factor: 4.584

2.  MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.

Authors:  Yan-Ran Wu; Hai-Jun Qi; Dan-Fang Deng; Ying-Ying Luo; Sheng-Lan Yang
Journal:  Tumour Biol       Date:  2016-05-17

3.  Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis.

Authors:  Kotaro Yamashita; Masayuki Watanabe; Shinji Mine; Tasuku Toihata; Ian Fukudome; Akihiko Okamura; Masami Yuda; Masaru Hayami; Naoki Ishizuka; Yu Imamura
Journal:  Surg Endosc       Date:  2018-04-11       Impact factor: 4.584

4.  Comparison of perioperative outcomes following hybrid minimally invasive versus open Ivor Lewis esophagectomy for esophageal cancer.

Authors:  Ju Sik Yun; Kook Joo Na; Sang Yun Song; Seok Kim; In Seok Jeong; Sang Gi Oh
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

5.  Postoperative short-term outcomes of minimally invasive versus open esophagectomy for patients with esophageal cancer: An updated systematic review and meta-analysis.

Authors:  Naeem M Akhtar; Donglai Chen; Yuhuan Zhao; David Dane; Yuhang Xue; Wenjia Wang; Jiaheng Zhang; Yonghua Sang; Chang Chen; Yongbing Chen
Journal:  Thorac Cancer       Date:  2020-04-20       Impact factor: 3.500

6.  QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer.

Authors:  Eleonora Pinto; Maria Teresa Nardi; Carlo Castoro; Marco Scarpa; Rita Marchi; Francesco Cavallin; Rita Alfieri; Luca Saadeh; Matteo Cagol; Ilaria Baldan; Elisabetta Saraceni; Matteo Parotto; Fabio Baratto; Cristina Caberlotto; Andrea Vianello
Journal:  Support Care Cancer       Date:  2020-06-22       Impact factor: 3.603

7.  Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.

Authors:  Cristian Turato; Melania Scarpa; Andromachi Kotsafti; Andrea Cappon; Santina Quarta; Alessandra Biasiolo; Francesco Cavallin; Elisabetta Trevellin; Vincenza Guzzardo; Matteo Fassan; Vanna Chiarion-Sileni; Carlo Castoro; Massimo Rugge; Roberto Vettor; Marco Scarpa; Patrizia Pontisso
Journal:  Cancer Sci       Date:  2019-04-15       Impact factor: 6.716

8.  Association Between the Use of a Mobile Health Strategy App and Biological Changes in Breast Cancer Survivors: Prospective Pre-Post Study.

Authors:  Mario Lozano-Lozano; Lucia Melguizo-Rodríguez; Carolina Fernández-Lao; Noelia Galiano-Castillo; Irene Cantarero-Villanueva; Lydia Martín-Martín; Manuel Arroyo-Morales
Journal:  J Med Internet Res       Date:  2019-08-14       Impact factor: 5.428

9.  Modified McKeown procedure with uniportal thoracoscope for upper or middle esophageal cancer: initial experience and preliminary results.

Authors:  Qi Wang; Wei Ping; Yixin Cai; Shengling Fu; Xiangning Fu; Ni Zhang
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

10.  Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis.

Authors:  Lu Lv; Weidong Hu; Yanchen Ren; Xiaoxuan Wei
Journal:  Onco Targets Ther       Date:  2016-10-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.